EVA System Africa

Home
Kenya
Nairobi
EVA System Africa

The EVA System is a powerful tool for cervical visualization and clinical tracking for health facilities and providers everywhere. Powered by MobileODT. Now.

About the EVA System:
The Enhanced Visual Assessment (EVA) System is a powerful tool that combines hardware, software and online portal features for cervical visualization and clinical tracking for health facilities and providers at all levels of care. About MobileODT:
MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.

28/08/2020

What is your take on the new guidelines published by the American Cancer Society?

If the pandemic has taught us anything, it's the more testing, the better. So why is the American Cancer Society recommending women get fewer tests?

27/08/2020

Bruising, rashes and other abnormalities of the skin are common physical symptoms that can be associated with child physical and sexual abuse. But what if it isn’t abuse?
https://bit.ly/3lbprNL

Bruising, rashes and other abnormalities of the skin are common physical symptoms that can be associated with child physical and sexual abuse. But what if it isn’t abuse? Assessing cases of child abuse is certainly no easy task. A major focus of determining whether or not abuse has occurred is to ...

26/08/2020

Who doesn't like being called a unicorn? Thank you for highlighting our technology for - it will definitely be a game changer in

AI point-of-care, wearable measuring breath & heart rate, Mammography Intelligent Assessment, minimally invasive surgery, Conformal Left Atrial Appendage

25/08/2020

Changing guidelines for recently updated by the American Cancer Society and the temporary guidelines in place because of -19 will have a profound impact on special populations in

The importance of addressing the needs of special populations in women’s health Join Dr. Sue Sherman, Ph.D. from Keel University, UK, as she shares her experience researching psychosocial aspects of patient experience and attitudes surrounding women’s health. Women’s health issues touch on som...

24/08/2020

It was an exciting week for us announcing our recent funding round and announcing our VisualCheck AI for . Can't wait to see what this week brings for - https://bit.ly/32nNYXm

Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. "In the last six months, Carrot launched a suite of new...

21/08/2020

Developing the field of to improve is critical now more than ever. https://bit.ly/2E94DFI

Israel's Sheba Medical Center holds competition in a bid to pilot devices that remotely monitor women's and fetal health

20/08/2020

Did you miss our webinar? You can catch the recording and learn how expert level are expanding access to with the EVA System's features -> https://bit.ly/3gYZcaW

RESOURCES WEBINAR TeleSANE: Responding to sexual assault survivors during the COVID-19 pandemic How telehealth solutions can help Watch our webinar to discuss how TeleSANE can provide a digital and connected solution to conducting forensic exams in light of the coronavirus crisis. Webinar discuss...

19/08/2020

Researchers from and show that two thirds of women delay due to fear of pain and discomfort. Our EVA System is a great tool for patient education to understand the process and reduce exam anxiety.

Two thirds of women are put off going for cervical screening due to fear or experience of pain and discomfort.

18/08/2020

We're excited to let the world know about our clinical decision support for examinations ! Send us a message and we'd happy to tell you more -> https://bit.ly/31XhvHo

VisualCheck provides clinicians with AI clinical decision support to assess for normal and abnormal cervical findings during colposcopy, predicting how highly trained colposcopists determine findings of the cervix.

17/08/2020

Thanks for covering our most recent funding and the appointment of our CEO Leon A. Boston to the MobileODT team. We are excited to get our out to the world and improve screening of https://bit.ly/2DXutwA

Israeli MedTech company MobileODT provides a crucial AI-powered screening advancement in the fight against the second most common cancer among women...

20/07/2020

"Virtual multidisciplinary conferences and telemedicine allow us to provide our model of care to all patients... telemedicine allows for close and timely follow-up without the burden of travel. Virtual multidisciplinary conferences can improve care by allowing same-day, real-time assessments of the urgency of patients’ needs and facilitating immediate triage." https://bit.ly/3eIZReK

Lessons from Virginia Mason.

10/07/2020

Self-screening for may help reduce rates of , but does America have enough expert colposcopists to handle the cases that are caught?

The National Cancer Institute plans to launch a study next year to assess whether at-home HPV tests can reduce rates of cervical cancer in the U.S.

Address

Nairobi

Website

http://www.mobileodt.com/

Alerts

Be the first to know and let us send you an email when EVA System Africa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to EVA System Africa:

Shortcuts

Want your practice to be the top-listed Clinic in Nairobi?

The EVAlution

About the EVA System: The Enhanced Visual Assessment (EVA) System is a powerful tool that combines hardware, software and online portal features for cervical visualization and clinical tracking for health facilities and providers at all levels of care. About MobileODT: MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.